May 15, 2012
Another quarter has zoomed by. And with it, FDA’s Office of Prescription Drug Promotion (OPDP), formerly known as the Division of Drug Marketing, Advertising and Communications (DDMAC), has issued a stream of regulatory action letters known as Notice of Violation … Continue reading →
May 4, 2012
Wondering by the end of the day how many people will post “May the 4th be with you” on Facebook. So far I am in double digits…. We are in May. Hard to believe. I am thinking that there are … Continue reading →
April 30, 2012
10 Count ‘em 10. That is how many Warning Letters the agency sent out last Friday to manufacturers and distributors of dietary supplements. The specific focus of the letters was products that were being marketed containing dimethylamylamine, also known as … Continue reading →
February 14, 2012
Each quarter Eye on FDA provides a brief recap of the regulatory action letters issued respecting the promotion of prescription drugs. The office that issues the letter underwent a change during 2011, changing its name in the process from the … Continue reading →
October 13, 2011
Last week it was noted that enforcement at DDMAC, newly renamed the Office of Prescription Drug Promotion (OPDP) has slowed down. Last quarter, the division, now an office, issued only four letters. Not only is it worthwhile to look at … Continue reading →